Innovative Medicines Canada challenges PMPRB guidelines in new judicial review
Innovative Medicines Canada (IMC) and a number of pharmaceutical companies have jointly commenced an application for judicial review of the … read more »
Health Canada continues review on COVID-19 vaccine
Health Canada has released a statement acknowledging that the UK Medicines and Healthcare Products Regulatory Agency has issued a temporary … read more »
Canada acts on drug export risks
Health Canada has announced a policy to restrict exports of key drugs at risk of shortages, partly in response to … read more »
Most Canadians could be vaccinated against COVID-19 by the end of 2021
Deputy chief public health officer Dr. Howard Njoo has said he is optimistic that the current vaccine front-runners can be … read more »
Canadian girl wins “drug lottery” to access spinal muscular atrophy treatment
A one-year-old girl in Alberta, Canada with spinal muscular atrophy type I, has been given access to Zolgensma, a novel … read more »
Trudeau proposes harmonisation of long-term care standards
In a telephone meeting with the premiers this week, Trudeau proposed harmonised national standards for long-term care, which are currently … read more »
PMPRB reports $2 billion increase in drugs spend in three years
Canada’s Patented Medicine Prices Review Board (PMPRB) has released a new report showing the dramatic increase in spending on drugs … read more »
Consultation opened for new Canadian guidelines
The Patented Medicines Pricing Review Board (PMPRB) has asked for comments on its proposed new guidelines, due to be enforced … read more »
PMPRB launches revised guidelines for budget impact
Patented medicines launched in Canada are subject to revised guidelines on budget impact analysis thanks to an updated version being … read more »
Canada moves to improve COVID-19 patient access
Health Canada, through Minister of Health, Patty Hajdu, has announced a raft of measures designed to accelerate patient access to … read more »
